State Of Wyoming Gracell Biotechnologies Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.45 - $6.07 $111 - $467	77 Added 43.26%	255 $0
Q1 2023 May 12, 2023	SELL	$1.8 - $2.5 $12 - $17	-7 Reduced 3.78%	178 $0
Q4 2022 Feb 14, 2023	BUY	$2.08 - $3.96 $326 - $621	157 Added 560.71%	185 $0
Q3 2022 Nov 14, 2022	BUY	$2.08 - $5.15 $58 - $144	28 New	28 $0

75.1K

Ticker GRCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,674,096
Description
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.